# Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks

> **NCT04422132** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Weill Medical College of Cornell University** · enrollment: 134 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** 5 days Radiation Therapy (32.5 Gy in 5 fractions)
- **RADIATION:** 20 days Radiation therapy (55 Gy in 20 fractions)

## Key facts

- **NCT ID:** NCT04422132
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-24
- **Primary completion:** 2025-12-31
- **Final completion:** 2033-12-31
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04422132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04422132, "Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04422132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*